BioStar Capital
Charlevoix, Michiganbiostarcapital.com
Overview
BioStar Capital is a uniquely structured venture capital firm focused on transformative medical technologies. Their team includes renowned healthcare clinicians and executives, medical thought leaders, and financial professionals, differentiating the firm within the industry and mitigating risk through its connected network and disciplined investment process. They invest in and nurtures transformative medical technologies with a primary emphasis on the cardiovascular and orthopedic sectors, the firm also invests in digital health, robotics, ophthalmology, neuromodulation, and biomaterials.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aria CV | Aug 2025 | Series C | Co-investor |
| Versa Vascular, Inc. | Jul 2025 | Series C | Co-investor |
| Field Medical | Jul 2025 | Series B | Lead |
| Amplitude Vascular Systems | Jan 2025 | Series B | Co-investor |
| Nectero Therapeutics | Apr 2024 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
